Thymosin alpha 1: A comprehensive review of the literature

doi:10.5501/wjv.v9.i5.67

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (37728)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

1198

WORD

335

HTML

31608

Figures (1-2)

646

Tables (1-2)

489

Sum=34276

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

375

Download

792

Sum=1167

Publishing Process of This Article

Item

Count

Browse

763

Download

1522

Sum=2285

Dec 15, 2020 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Virol. Dec 15, 2020; 9(5): 67-78
Published online Dec 15, 2020. doi: 10.5501/wjv.v9.i5.67

Table 2 Summary of ongoing clinical trials of thymosin and coronavirus disease 2019

Clinical trial number	Location	Status	Condition	Intervention	Results
NCT04428008	United States	Not yet recruiting	COVID-19	Drug: Thymalfasin	Not yet available
NCT04487444	United States	Recruiting	COVID-19	Drug: Thymalfasin	Not yet available
NCT04268537	China	Not yet recruiting	COVID-19	Drug: PD-1 blocking antibody + standard treatment; Drug: Thymosin + Standard treatment; Other: Standard treatment	Not yet available
NCT04320238	China	Recruiting	COVID-19	Drug: Recombinant human interferon Alpha-1b; Drug: Thymosin alpha 1	Not yet available

Data retrieved from clinicaltrials.gov on October 5^th, 2020. COVID-19: Coronavirus disease 2019.

Citation: Dominari A, Hathaway III D, Pandav K, Matos W, Biswas S, Reddy G, Thevuthasan S, Khan MA, Mathew A, Makkar SS, Zaidi M, Maher M, Beas R, Castaneda V, Paul T, Halpern J, Baralt D. Thymosin alpha 1: A comprehensive review of the literature. World J Virol 2020; 9(5): 67-78
URL: https://www.wjgnet.com/2220-3249/full/v9/i5/67.htm
DOI: https://dx.doi.org/10.5501/wjv.v9.i5.67